Advanced Therapy Medicinal Products as Potential Therapeutic Strategy against COVID-19 and Immune-Related Disorders.

Mallis, Panagiotis; Michalopoulos, Efstathios; Stavropoulos-Giokas, Catherine

Mallis, Panagiotis; Michalopoulos, Efstathios; Stavropoulos-Giokas, Catherine.

Afiliação

Mallis P; Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens (BRFAA), 115 27 Athens, Greece.
Michalopoulos E; Immunology Department & National Tissue Typing Center, General Hospital of Athens "Gennimatas", 154 Mesogeion Ave., 115 27 Athens, Greece.
Stavropoulos-Giokas C; Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens (BRFAA), 115 27 Athens, Greece.

Int J Mol Sci ; 25(5)2024 Mar 06.

Article em En | MEDLINE | ID: mdl-38474324

ABSTRACT

ABSTRACT

Advanced Therapy Medicinal Products (ATMPs) comprise a heterogenous class of innovative medicinal products, which further require extensive preclinical and clinical assessments before their broader use in the general population [...].

Assuntos

COVID-19; Humanos; Terapia Baseada em Transplante de Células e Tecidos; Terapia Genética

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Grécia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google